Yahoo · Oct 20, 2026
Integra LifeSciences (IART) Q3 Earnings Report Preview: What To Look For
Medical device company Integra LifeSciences (NASDAQ:IART) will be announcing earnings results this Wednesday before market open. Here’s what to look for.
NASDAQ · IART
Integra LifeSciences Holdings Corporation
Healthcare · Medical - Devices
$11.91
Down-$0.42 (-3.37%)
Updated Oct 25, 2026, 12:03 AM
SID Score
3.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.1B
- P/E ratio
- -2.18
- Dividend yield
- 0.00%
- 52-week range
- $8.70 – $20.49
- Volume
- 1.21M
- Avg. volume
- 1.05M
Price performance · IART
IART price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 23, 2026
IART closed at $11.91 after 20 trading sessions, down 26.80% for the selected period.
- Last close
- $11.91
- Period change
- -26.80%
- Period low
- $11.84
- Period high
- $16.64
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | $12.12 | $12.396 | $11.815 | $11.91 | 1.21M |
| Oct 22, 2026 | $11.69 | $12.36 | $11.66 | $12.325 | 1.39M |
| Oct 21, 2026 | $12.77 | $13.745 | $11.57 | $11.84 | 2.02M |
| Oct 20, 2026 | $13.51 | $13.76 | $13.27 | $13.33 | 1.31M |
| Oct 19, 2026 | $13.13 | $13.49 | $13.1113 | $13.45 | 726.14K |
| Oct 16, 2026 | $13.65 | $13.83 | $13.10 | $13.21 | 831.02K |
| Oct 15, 2026 | $13.38 | $13.64 | $13.285 | $13.53 | 1.33M |
| Oct 14, 2026 | $13.45 | $13.79 | $12.92 | $13.175 | 1.11M |
| Oct 13, 2026 | $14.05 | $14.28 | $13.66 | $13.85 | 823.02K |
| Oct 12, 2026 | $13.43 | $14.03 | $13.42 | $13.98 | 893.71K |
| Oct 9, 2026 | $13.38 | $13.86 | $13.23 | $13.44 | 1.23M |
| Oct 8, 2026 | $12.86 | $13.435 | $12.825 | $13.41 | 1.46M |
| Oct 7, 2026 | $13.19 | $13.46 | $12.98 | $13.00 | 1.41M |
| Oct 6, 2026 | $13.46 | $13.51 | $12.88 | $13.32 | 1.37M |
| Oct 5, 2026 | $12.65 | $13.485 | $12.35 | $13.29 | 1.86M |
| Oct 2, 2026 | $13.31 | $14.00 | $12.63 | $12.68 | 2.7M |
| Oct 1, 2026 | $16.21 | $16.45 | $15.88 | $16.09 | 652.94K |
| Sep 30, 2026 | $16.67 | $16.67 | $16.14 | $16.28 | 768.91K |
| Sep 29, 2026 | $16.27 | $16.765 | $15.80 | $16.64 | 1.01M |
| Sep 28, 2026 | $16.04 | $16.27 | $15.86 | $16.27 | 479.05K |
Latest IART news
The latest Smart Investors Daily articles mentioning IART.
Stock researchCompany · Overview
Company
Market Activity
Research & News
IART research
Overview
Company profile and research snapshot.
Company profile
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $15.00
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 22, 2026 | JP Morgan | Underweight | — |
| Oct 22, 2026 | Citizens | Market Outperform | — |
| Oct 22, 2026 | Wells Fargo | Equal-Weight | — |
| Oct 22, 2026 | BMO Capital | Market Perform | — |
| Oct 22, 2026 | Citigroup | Neutral | — |
News briefing
No generated briefing is available yet.
Yahoo · Oct 19, 2026
Integra Announces Completion of Refinancing Transactions
PRINCETON, N.J., Oct. 19, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it has closed a private offering of $450.0 million aggregate principal amount of 9.500% senior secured notes due 2033 (the “Notes”). In addition, Integra announced today that it has amended and restated its existing credit facility, with an overall size of approximately $1.65 billion consisting of (i) a $600 million senior secured revolving credit facility with a five y
Yahoo · Oct 16, 2026
Integra LifeSciences to Highlight ENT and Instruments Portfolios and Sponsor New Clinical Research Presentations at AAO-HNSF 2026 Annual Meeting
ACCLARENT AERA® Eustachian Tube Treatment Simulation of a minimally invasive ear procedure using the ACCLARENT AERA® Eustachian Tube Treatment. PRINCETON, N.J., Oct. 16, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a global leader in medical technology, today announced its participation in the 2026 American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF) Annual Meeting & OTO EXPO, taking place October 17-20 in Los Angeles, California. A
Yahoo · Oct 16, 2026
3 Healthcare Stocks That Concern Us
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising as the industry has posted a 31.4% gain over the past six months, beating the S&P 500 by 21.7 percentage points.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
